1 Home > 2 Business Areas > 3 Pharmaceuticals


Janssen aspires after a world without illness. This Johnson & Johnson pharmaceuticals company strives to use the best proprietary and external scientific findings to help prevent, stop, treat and heal illnesses. A commitment to patients is what drives Janssen to provide people around the world with innovative products, services and solutions. Janssen has operated its branch office in Switzerland since 1948 with a focus on clinical research and distribution.

Through research and development in the area of prescription-based drugs, including biologics and other innovative treatment methods, the Janssen Pharmaceutical Companies of Johnson & Johnson are dealing with the most devastating and complicated illnesses of our time. In Switzerland, the Johnson & Johnson companies Cilag and Janssen are among the largest manufacturers in the pharmaceuticals industry. Using high-tech technologies and processes at its production facility in Schaffhausen, Cilag AG manufactures a wide variety of drugs in the form of tablets, capsules and suppositories. Since 2017, the Johnson & Johnson Family of Companies has also included the biopharmaceutical company Actelion. Pharmaceutical research at Johnson & Johnson is focused on six therapeutic areas:

  • Cardiovascular and metabolic diseases
  • Immunology
  • Infectious diseases and vaccines
  • Neurology
  • Oncology
  • Pulmonary arterial hypertension

By developing new products and innovative processes, the company has made significant contributions to the advancement of the treatment of many diseases. Five of its medicines have been included in the World Health Organization's list of the most important medications in the world.

For further information on the Pharmaceuticals business area of Johnson & Johnson, please visit the international website: https://www.jnj.com/healthcare-products/prescription



Johnson & Johnson (Corporate) | www.jnj.com